Reata Pharmaceuticals, Inc. - (RETA): Price and Financial Metrics
RETA Price/Volume Stats
| Current price | $172.36 | 52-week high | $172.46 |
| Prev. close | $172.32 | 52-week low | $21.83 |
| Day low | $172.32 | Volume | 1,988,500 |
| Day high | $172.46 | Avg. volume | 1,091,032 |
| 50-day MA | $158.53 | Dividend yield | N/A |
| 200-day MA | $95.04 | Market Cap | 6.58B |
RETA Stock Price Chart Interactive Chart >
Reata Pharmaceuticals, Inc. - (RETA) Company Bio
Reata Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on identifying, developing, and commercializing product candidates that modulate the activity of key regulatory proteins involved in the biology of mitochondrial function, oxidative stress, and inflammation to address the unmet medical needs of patients with various serious or life-threatening diseases. The company was founded in 2002 and is based in Irving, Texas.
RETA Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
RETA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 395.86% |
| 5-year | 25.81% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | 0.00% |
| 2022 | 44.07% |
| 2021 | -78.67% |
| 2020 | -39.53% |